Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
100%
Infectious Disease
98%
Plasmodium falciparum
82%
Parasite
62%
Prevalence
59%
Malaria
50%
Praziquantel
27%
Antigen
26%
Leishmania
24%
Haplotype
23%
Cutaneous Leishmaniasis
22%
Loop-Mediated Isothermal Amplification
21%
Phlebotominae
21%
Population Structure
21%
Immunoglobulin E
21%
Anopheles
21%
Onchocerciasis
21%
Lymphatic Filariasis
21%
Single Nucleotide Polymorphism
19%
Plasmodium
18%
Schistosoma Mansoni
17%
Chloroquine
16%
Immunoglobulin G4
15%
Seropositivity
14%
Genetic Variability
13%
Susceptibility
13%
Schistosomiasis
13%
Allele
12%
Blood Plasma
12%
Sulfadoxine/Pyrimethamine
12%
Human Immunodeficiency Virus
12%
Schistosoma
12%
Toxoplasma
11%
Seroprevalence
11%
Antimalarial Drug Resistance
10%
Antimalarial Agent
10%
Balancing Selection
10%
Visceral Leishmaniasis
10%
Next Generation Sequencing
10%
Cryptosporidium
10%
Gene Dosage
10%
Immunoglobulin M Antibody
10%
Toxoplasma gondii
10%
Body Mass
10%
Body Composition
10%
Schistosoma Japonicum
10%
Immunoproteomics
10%
Egg Production
10%
Antibiotic Resistance
10%
Species Diversity
10%
Gene Linkage Disequilibrium
10%
Toxoplasmosis
10%
Medicinal Plant
10%
KIR3DL1
10%
Cercaria
10%
Geographic Distribution
10%
Aedes aegypti
10%
Aedes
10%
Infection Resistance
10%
Genetic Marker
10%
Drug Therapy
10%
Epidemiology
10%
Diptera
10%
Cohort Effect
10%
Yellow Fever
10%
Infectious Agent
9%
Malaria Control
9%
Morbidity
9%
Sergentomyia
9%
Polymerase Chain Reaction
9%
Multiplicity of Infection
8%
Real-Time Polymerase Chain Reaction
7%
Digestive Function
7%
Anopheles Gambiae
7%
Sporozoite
6%
Allergen
6%
Drug Resistance
6%
Erythrocyte
6%
Bacterium
6%
IC50
5%
Intraspecific Competition
5%
Frequency Dependent Selection
5%
Leishmaniasis
5%
Infection Rate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parasite
34%
Malaria
34%
Diseases
32%
Plasmodium falciparum
25%
Antimalarial Agent
25%
Prevalence
22%
Leishmania
21%
Medicinal Plant
21%
Onchocerciasis
21%
Artesunate
19%
IC50
19%
Artemisinin
17%
Infection
17%
Malaria Falciparum
17%
Amodiaquine
17%
Chloroquine
16%
Drug Discovery
16%
Drug Resistance
15%
Trypanosoma
15%
Morinda lucida
15%
Pyrimethamine Plus Sulfadoxine
14%
Sulfadoxine
13%
Yellow Fever
13%
Combination Therapy
12%
Iridoid
10%
Antitrypanosomal
10%
Buruli Ulcer
10%
Plasmodium
10%
Mefloquine
10%
Virus Infection
10%
Dihydropteroate Synthase
10%
Anemia
10%
Cerebral Malaria
10%
Glucose 6 Phosphate Dehydrogenase Deficiency
10%
Cercaria
10%
Infection Resistance
10%
Bite
10%
Aedes
10%
Aedes aegypti
10%
Diptera
10%
Strongyloidiasis
10%
Bacterial Infection
10%
Antibiotic Resistance
10%
Infectious Agent
9%
Praziquantel
8%
Chemotherapy Regimens
7%
Elimination
6%
Bacterium
6%
Artemether Plus Benflumetol
5%
SARS Coronavirus
5%
Trypanothione Reductase
5%
Uridine Diphosphate
5%
Monotherapy
5%
Dihydroartemisinin
5%
Disease Carrier
5%
Ivermectin
5%
Leishmaniasis
5%
Medicine and Dentistry
Parasite (Microbiology)
43%
Loop-Mediated Isothermal Amplification
32%
Medical Research
32%
Malaria Falciparum
25%
Infection
21%
Molecular Inversion Probe
21%
Genetics
21%
Neglected Tropical Diseases
18%
Prevalence
16%
Malaria
16%
Plasmodium falciparum
14%
Antimalarial Drug Resistance
14%
Buruli Ulcer
14%
DNA Extraction
13%
Drug Resistance
13%
Mycobacterium ulcerans
12%
Schistosomiasis
11%
Rapid Diagnostic Test
11%
Lymphatic Filariasis
10%
Schistosoma Mansoni
10%
Schistosoma
10%
Helminth
10%
Bacterial Infection
10%
Next Generation Sequencing
10%
Leishmania
10%
Cutaneous Leishmaniasis
10%
Population Structure
10%
Visceral Leishmaniasis
10%
Non Communicable Disease
10%
Infection Resistance
10%
Antibiotic Resistance
10%
Sulfadoxine/Pyrimethamine
10%
Pathogen
8%
Drug Administration
8%
Diseases
8%
Chloroquine
8%
Polymerase Chain Reaction
7%
Resistance Mutation
7%
Plasmodium
6%
Sulfadoxine
6%
Bacterium
6%
Health Care Cost
5%
Infectious Disease
5%